NDA 065037 describes IDARUBICIN HYDROCHLORIDE, which is a drug marketed by
Fresenius Kabi Usa,
Hikma,
Meitheal,
Rising,
Sandoz, and
Teva Parenteral, and is included in seven NDAs. It is available from
one supplier. Additional details are available on the
IDARUBICIN HYDROCHLORIDE profile page.
The generic ingredient in IDARUBICIN HYDROCHLORIDE is
idarubicin hydrochloride. There are six
drug master file entries for this compound. Two
suppliers are listed for this compound. Additional details are available on the
idarubicin hydrochloride profile page.